Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Clown-Free Zone... sorry, no clowns allowed -- Ignore unavailable to you. Want to Upgrade?

To: pater tenebrarum who wrote (103032)	5/17/2001 4:18:22 PM
From: yard_man	Read Replies (1) \| Respond to of 436258

CSCO seems to keep hitting his head on 20 ... and ducking back down

To: pater tenebrarum who wrote (103032)	5/17/2001 4:20:57 PM
From: patron_anejo_por_favor	Read Replies (1) \| Respond to of 436258

Pharmacia to "smell the glove" tomorrow: cbs.marketwatch.com NEW YORK (CBS.MW) -- Two studies of a drug combination used to treat colon cancer have been suspended after researchers discovered that the regimen was causing an unexpectedly high death rate. Because of the urgency of the situation, researchers with the National Cancer Institute reported their findings early in a letter in this week's edition of the New England Journal of Medicine, published on Thursday. Publication was scheduled for June 21. The drugs given to patients in the studies are irinotecan, marketed by Pharmacia (PHA: news, msgs, alerts) as Camptosar, and leucovorin combined with chemotherapy drugs.

To: pater tenebrarum who wrote (103032)	5/17/2001 4:23:03 PM
From: Crimson Ghost	Read Replies (1) \| Respond to of 436258

I sold a third of of my gold funds today. Two sources I greatly respect -- Slider on the Black who posts on the oil services thread, and Sandspring Advisors -- both of whom have been very bullish on gold stocks for quite some time -- opined today that now is the time to take some winnings off the table.

To: pater tenebrarum who wrote (103032)	5/17/2001 5:04:48 PM
From: Haim R. Branisteanu	Read Replies (4) \| Respond to of 436258

Heinz, you will love this one - DELL reports earnings on an EXTENDED QUARTER well for all April 30 was the end of quarter but not for DELL it was a week later May 4th. What we will not do to massage numbers. Net income fell to $462 million, or 17 cents a share, from $466 million, or 17 cents, a year earlier. Sales in the period ended May 4 rose 10 percent to $8.03 billion from $7.28 billion, the company said in a statement. Gross margin narrowed to 18 percent. Haim